Citation:Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, et al 2016

From Cancer Guidelines Wiki

Citation


Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, et al. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis. JAMA Oncol 2016 Jan;2(1):65-73 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26426573.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Ovarian suppression during chemotherapyDr Wanyuan Cui MBBS BMEDSCI FRACPcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Ovarian suppression with GnRH analogues